IDH1 and glioblastoma: FREM2 appeared a relatively weak diagnostic biomarker as it showed low or statistically unreliable AUC values for almost all pairwise comparisons except “glioblastoma, IDH-wildtype” vs “oligodendroglioma, IDH-mutant, and 1p/19q-codeleted”.